Epigenetic Regulation of WNT Signaling Pathway Genes in Inflammatory Bowel Disease (IBD) Associated Neoplasia

[1]  B. Levin,et al.  Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: a joint guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology. , 2008, Gastroenterology.

[2]  R. Holcombe,et al.  Wnt Pathway-Related Gene Expression in Inflammatory Bowel Disease , 2008, Digestive Diseases and Sciences.

[3]  P. Bryant,et al.  Expression of Wnt pathway components frizzled and disheveled in colon cancer arising in patients with inflammatory bowel disease. , 2007, Oncology reports.

[4]  H. Hermeking,et al.  DNA Stool Test for Colorectal Cancer: Hypermethylation of the Secreted Frizzled-Related Protein-1 Gene , 2007, Diseases of the colon and rectum.

[5]  E. Kuipers,et al.  Wnt pathway-related gene expression during malignant progression in ulcerative colitis. , 2007, Acta histochemica.

[6]  Wei Chen,et al.  Comparing the DNA Hypermethylome with Gene Mutations in Human Colorectal Cancer , 2007, PLoS genetics.

[7]  T. Moriyama,et al.  Hypermethylation of p14ARF May Be Predictive of Colitic Cancer in Patients with Ulcerative Colitis , 2007 .

[8]  D. Rubin,et al.  Surveillance for cancer and dysplasia in inflammatory bowel disease. , 2006, Gastroenterology clinics of North America.

[9]  M. Fraga,et al.  Epigenetic inactivation of the Wnt antagonist DICKKOPF-1 (DKK-1) gene in human colorectal cancer , 2006, Oncogene.

[10]  A. Forbes,et al.  Thirty-year analysis of a colonoscopic surveillance program for neoplasia in ulcerative colitis. , 2006, Gastroenterology.

[11]  S. Hanauer,et al.  Inflammatory bowel disease: Epidemiology, pathogenesis, and therapeutic opportunities , 2006, Inflammatory bowel diseases.

[12]  S. Baylin,et al.  DNA methylation and gene silencing in cancer , 2005, Nature Clinical Practice Oncology.

[13]  D. Jewell,et al.  Cancer surveillance in ulcerative colitis , 2005, The British journal of surgery.

[14]  H. Clevers,et al.  Wnt control of stem cells and differentiation in the intestinal epithelium. , 2005, Experimental cell research.

[15]  T. Ullman.  Preventing neoplastic progression in ulcerative colitis. , 2005, Journal of clinical gastroenterology.

[16]  C. Compton,et al.  APC promoter hypermethylation contributes to the loss of APC expression in colorectal cancers with allelic loss on 5q1 , 2004, Cancer biology & therapy.

[17]  Wei Dong Chen,et al.  Epigenetic inactivation of SFRP genes allows constitutive WNT signaling in colorectal cancer , 2004, Nature Genetics.

[18]  J. Herman,et al.  Gene silencing in cancer in association with promoter hypermethylation. , 2003, The New England journal of medicine.

[19]  A. Nakao,et al.  Methylation-mediated silencing of SOCS-1 gene in hepatocellular carcinoma derived from cirrhosis. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.

[20]  K. Matsuda,et al.  Earlier surveillance colonoscopy programme improves survival in patients with ulcerative colitis associated colorectal cancer: results of a 23-year surveillance programme in the Japanese population , 2003, British Journal of Cancer.

[21]  Yoshiaki Kawano,et al.  Secreted antagonists of the Wnt signalling pathway , 2003, Journal of Cell Science.

[22]  M. Gregor,et al.  Epigenetic control of the E‐cadherin gene (CDH1) by CpG methylation in colectomy samples of patients with ulcerative colitis , 2002, Genes, chromosomes & cancer.

[23]  Bert Vogelstein,et al.  DNMT1 and DNMT3b cooperate to silence genes in human cancer cells , 2002, Nature.

[24]  F. Waldman,et al.  The APC/β‐catenin pathway in ulcerative colitis–related colorectal carcinomas , 2002, Cancer.

[25]  M. Peppercorn,et al.  Ulcerative colitis , 2002, The Lancet.

[26]  A. Zorn,et al.  Wnt signalling: Antagonistic Dickkopfs , 2001, Current Biology.

[27]  N. Ahuja,et al.  Accelerated age-related CpG island methylation in ulcerative colitis. , 2001, Cancer research.

[28]  K. Abrams,et al.  The risk of colorectal cancer in ulcerative colitis: a meta-analysis , 2001, Gut.

[29]  P. Laird,et al.  Fields of aberrant CpG island hypermethylation in Barrett's esophagus and associated adenocarcinoma. , 2000, Cancer research.

[30]  J. Herman,et al.  Microsatellite instability in inflammatory bowel disease-associated neoplastic lesions is associated with hypermethylation and diminished expression of the DNA mismatch repair gene, hMLH1. , 2000, Cancer research.

[31]  S. Nishizuka,et al.  E-Cadherin gene promoter hypermethylation in primary human gastric carcinomas. , 2000, Journal of the National Cancer Institute.

[32]  J. Herman,et al.  DNA hypermethylation in tumorigenesis: epigenetics joins genetics. , 2000, Trends in genetics : TIG.

[33]  T. Pramila,et al.  Interaction of Frizzled Related Protein (FRP) with Wnt Ligands and the Frizzled Receptor Suggests Alternative Mechanisms for FRP Inhibition of Wnt Signaling* , 1999, The Journal of Biological Chemistry.

[34]  J. Potter,et al.  Colorectal cancer: molecules and populations. , 1999, Journal of the National Cancer Institute.

[35]  C. Albanese,et al.  The cyclin D1 gene is a target of the beta-catenin/LEF-1 pathway. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[36]  H. Clevers,et al.  Identification of APC2, a homologue of the adenomatous polyposis coli tumour suppressor , 1999, Current Biology.

[37]  Y. Nakamura,et al.  Identification of a brain-specific APC homologue, APCL, and its interaction with beta-catenin. , 1998, Cancer research.

[38]  A. Sparks,et al.  Identification of c-MYC as a target of the APC pathway. , 1998, Science.

[39]  C. Hsieh,et al.  Hypermethylation of the p16INK4a promoter in colectomy specimens of patients with long-standing and extensive ulcerative colitis. , 1998, Cancer research.

[40]  A. Ekbom,et al.  Is colonoscopic surveillance reducing colorectal cancer mortality in ulcerative colitis? A population based case control study , 1998, Gut.

[41]  R. Nusse,et al.  Wnt signaling: a common theme in animal development. , 1997, Genes & development.

[42]  C. FordAlexander,et al.  ULCERATIVE colitis. , 1997, Journal of the American Medical Association.

[43]  I. Talbot,et al.  Colorectal cancer in idiopathic inflammatory bowel disease. , 1996, Seminars in diagnostic pathology.

[44]  J. Herman,et al.  Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[45]  Michael Kühl,et al.  Functional interaction of β-catenin with the transcription factor LEF-1 , 1996, Nature.

[46]  A. Axon,et al.  Colonic cancer surveillance in ulcerative colitis is not essential for every patient. , 1995, European journal of cancer.

[47]  N. Harpaz,et al.  Adenomatous polyposis coli gene mutations in ulcerative colitis-associated dysplasias and cancers versus sporadic colon neoplasms. , 1995, Cancer research.

[48]  C. Williams,et al.  Factors affecting the outcome of endoscopic surveillance for cancer in ulcerative colitis. , 1994, Gastroenterology.

[49]  J. Baillie,et al.  Failure of colonoscopic surveillance in ulcerative colitis. , 1994, Gastrointestinal endoscopy.

[50]  K. Kinzler,et al.  Molecular genetic profiles of colitis-associated neoplasms. , 1994, Gastroenterology.

[51]  P. Rabinovitch,et al.  Mutations in the p53 gene: an early marker of neoplastic progression in ulcerative colitis. , 1994, Gastroenterology.

[52]  S. Leeder,et al.  A population based study , 1993, The Medical journal of Australia.

[53]  R. Haggitt,et al.  Colonoscopic surveillance reduces mortality from colorectal cancer in ulcerative colitis. , 1993, Gastroenterology.

[54]  N. Harpaz,et al.  p53 point mutations in dysplastic and cancerous ulcerative colitis lesions. , 1993, Gastroenterology.

[55]  P. Rabinovitch,et al.  Neoplastic progression in ulcerative colitis: histology, DNA content, and loss of a p53 allele. , 1992, Gastroenterology.

[56]  M. Kimmey,et al.  DNA aneuploidy in colonic biopsies predicts future development of dysplasia in ulcerative colitis. , 1992, Gastroenterology.

[57]  P. Munkholm,et al.  Colorectal cancer risk and mortality in patients with ulcerative colitis. , 1992, Gastroenterology.

[58]  B. Korelitz,et al.  Surveillance in the routine management of ulcerative colitis: the predictive value of low-grade dysplasia. , 1992, Gastroenterology.

[59]  S Ichii,et al.  Somatic mutations of the APC gene in colorectal tumors: mutation cluster region in the APC gene. , 1992, Human molecular genetics.

[60]  H. Adami,et al.  Ulcerative colitis and colorectal cancer. A population-based study. , 1990, The New England journal of medicine.

[61]  H. Adami,et al.  Increased risk of large-bowel cancer in Crohn's disease with colonic involvement , 1990, The Lancet.

[62]  J. Jass,et al.  Observer study of the grading of dysplasia in ulcerative colitis: comparison with clinical outcome. , 1989, Human pathology.

[63]  A. Price,et al.  Observer variation in the assessment of dysplasia in ulcerative colitis , 1988, Histopathology.

[64]  Robert H. Collins,et al.  Colon cancer, dysplasia, and surveillance in patients with ulcerative colitis. A critical review. , 1987, The New England journal of medicine.

[65]  D. Ransohoff,et al.  Dysplasia in inflammatory bowel disease: standardized classification with provisional clinical applications. , 1983, Human pathology.

[66]  S. Geller,et al.  Cancer in universal and left-sided ulcerative colitis: factors determining risk. , 1979, Gastroenterology.

[67]  Makoto Watanabe,et al.  Aberrant DNA methylation in ulcerative colitis without neoplasia. , 2008, Hepato-gastroenterology.

[68]  W. de Lau,et al.  WNT signaling in the normal intestine and colorectal cancer. , 2007, Frontiers in bioscience : a journal and virtual library.

[69]  T. Moriyama,et al.  Hypermethylation of p14 (ARF) may be predictive of colitic cancer in patients with ulcerative colitis. , 2007, Diseases of the colon and rectum.

[70]  谷口 博昭.  Frequent epigenetic inactivation of Wnt inhibitory factor-1 in human gastrointestinal cancers , 2006 .

[71]  K. Chew,et al.  Altered Distribution of β-Catenin, and Its Binding Proteins E-Cadherin and APC, in Ulcerative Colitis–Related Colorectal Cancers , 2001, Modern Pathology.

[72]  Y. Nakamura,et al.  APCL, a central nervous system-specific homologue of adenomatous polyposis coli tumor suppressor, binds to p53-binding protein 2 and translocates it to the perinucleus. , 2000, Cancer research.

[73]  R Grosschedl,et al.  Functional interaction of beta-catenin with the transcription factor LEF-1. , 1996, Nature.

[74]  E. Furth,et al.  The bcl-2 proto-oncogene and the gastrointestinal epithelial tumor progression model. , 1995, The American journal of pathology.

[75]  N. Perrimon,et al.  The Drosophila segment polarity gene dishevelled encodes a novel protein required for response to the wingless signal. , 1994, Genes & development.

[76]  A. Ekbom.  Ulcerative Colitis and Colorectal Cancer , 1991 .